ARTICLE | Clinical News
QGC001: Phase IIa data
October 17, 2016 7:00 AM UTC
Top-line data from the double-blind, placebo-controlled, crossover, French Phase IIa 2QG1 trial in 34 patients with moderate grade I or II hypertension showed that oral QGC001 led to “positive signals...